Explore 3 Stock Ideas & Industry Insights Download Free Report

News

RTX Senior Vice President and Treasurer Kevin DaSilva Sells Over 7,000 Shares in Two Transactions

RTX Corp disclosed that Kevin G. DaSilva, Senior Vice President and Treasurer, sold a combined 7,010 common shares across two separate transactions conducted on July 24 and July 28, 2026. The executive disposed of 4,760 shares at $213.62 per share and 2,250 shares at …

Vinay Lochav | 28 July 2026

RTX Director Tracy Atkinson Sells 2,295 Shares as Defense Contractor Updates Holdings

RTX Corp director Tracy A. Atkinson sold 2,295 shares of the aerospace and defense contractor on July 27, 2026, according to a regulatory filing published July 28, 2026. The transaction, executed at an average price of $218.05 per share, reduces Atkinson's direct beneficial ownership …

Shwetambri Chauhan | 28 July 2026

RTX President of Collins Aerospace Executes Stock Transactions Totaling Thousands of Shares

Troy D. Brunk, President of Collins Aerospace at RTX Corp, completed multiple stock transactions on July 24, 2026, involving the acquisition and disposition of common shares and the settlement of stock appreciation rights. The transactions reflect routine equity compensation activity and changes in beneficial …

Anjali Anand | 28 July 2026

Axalta Reports Second Quarter 2026 Results Ahead of Shareholder Vote on AkzoNobel Merger

Axalta Coating Systems Ltd. disclosed second quarter 2026 financial results showing net sales growth of 3% to $1.346 billion and adjusted EBITDA expansion to $305 million, as the company advances toward shareholder and regulatory approval of its proposed merger of equals with Akzo Nobel …

Shwetambri Chauhan | 28 July 2026

Axalta Reports Record Adjusted EBITDA in Q2 2026 Ahead of AkzoNobel Merger Vote

Axalta Coating Systems Ltd. disclosed second quarter 2026 financial results showing adjusted EBITDA growth and record earnings per share, even as net income declined due to merger-related expenses. The disclosure was filed in connection with the pending "merger of equals" transaction with Akzo Nobel …

Shwetambri Chauhan | 28 July 2026

Axalta Reports Record Adjusted EBITDA of $305 Million in Q2 2026 as Merger with AkzoNobel Advances

Axalta Coating Systems Ltd. disclosed strong second quarter 2026 results on July 28, 2026, reporting record adjusted EBITDA of $305 million and adjusted diluted earnings per share of $0.72, up 13% year-over-year. The company achieved net sales of $1.35 billion, representing 3% year-over-year growth, …

Aakashdeep | 28 July 2026

EigenQ Strengthens Leadership Ahead of Silicon Valley Acquisition Corp. Merger

EigenQ, Inc., a quantum technology company developing post-quantum cryptography and quantum-safe infrastructure solutions, announced executive leadership changes on July 28, 2026, as it prepares for its planned merger with Silicon Valley Acquisition Corp. The company appointed Mark Pecen as Vice Chairman and promoted Alexander …

Vinay Lochav | 28 July 2026

EigenQ Strengthens Executive Leadership With Vice Chairman Appointment and Chief Information Security Officer Promotion Ahead of SVAQ Merger

EigenQ Inc., a quantum technology company developing post-quantum cryptography and quantum-safe infrastructure solutions, announced significant executive leadership changes on July 28, 2026. The company appointed Mark Pecen as Vice Chairman and promoted Alexander Truskovsky to Chief Information Security Officer, moves designed to accelerate operational …

Manish Choudhary | 28 July 2026

Robinhood Ventures Fund I Executes Series of Share Sales, Reducing Beneficial Ownership Position

Robinhood Ventures Fund I, a director and 10% owner of Robinhood Markets, Inc. (NASDAQ: HOOD), disclosed a series of share sales executed between July 24 and July 27, 2026. The fund sold approximately 17,953 common shares of beneficial interest across four separate transactions at …

Nitish Kishor | 28 July 2026

RA Capital Management Increases Stake in Artiva Biotherapeutics With $412,000 Share Purchase

RA Capital Management and affiliated funds disclosed a purchase of 41,319 shares of Artiva Biotherapeutics Inc. (NASDAQ: ARTV) on July 24, 2026, at a weighted average price of $9.99 per share. The transaction, reported on July 28, 2026, reflects continued investment activity by the …

Vinay Lochav | 28 July 2026
Support

Hi! How can we help you today?

Loading…